Browse Category

Stock Market News 9 January 2026

D-Wave Quantum stock slips as $550 million Quantum Circuits deal puts dilution in focus

D-Wave Quantum stock slips as $550 million Quantum Circuits deal puts dilution in focus

D-Wave Quantum shares fell 3.1% Thursday after announcing a $550 million cash-and-stock deal to acquire Quantum Circuits. The stock traded between $28.66 and $30.44 on volume of 38.7 million shares. The deal’s stock portion uses a 10-day VWAP with a collar between $22.30 and $39.03 per share. Closing is expected in late January, pending antitrust review and shareholder approval.
Why Qualcomm stock moved: Volkswagen’s 2027 chip plan and Samsung 2nm talks

Why Qualcomm stock moved: Volkswagen’s 2027 chip plan and Samsung 2nm talks

Qualcomm shares rose 0.9% to $181.87 Thursday after Volkswagen named it main chip supplier for a new software platform launching in 2027. The stock traded between $176.51 and $184.29. Qualcomm is also in talks with Samsung to manufacture chips using a two-nanometre process. Investors await Friday’s U.S. jobs report and Qualcomm’s Feb. 4 earnings.
UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

U.S. House committees summoned UnitedHealth and four other insurers to testify on coverage affordability Jan. 22. UnitedHealth shares rose 1.5% to $346.85 after Wolfe Research raised its price target to $400. The company reports 2025 earnings and 2026 guidance Jan. 27. Senators also accused UnitedHealth of withholding documents in a nursing home care probe.
Goldman Sachs stock slips after Apple Card handoff to JPMorgan — what Wall Street watches next

Goldman Sachs stock slips after Apple Card handoff to JPMorgan — what Wall Street watches next

Goldman Sachs will transfer the Apple Card program to JPMorgan Chase over 24 months, ending its role as issuer. Goldman expects a $0.46 boost to Q4 2025 EPS, offset by $2.26 billion in loan markdowns and contract costs. GS shares fell 0.66% to $934.83 Thursday. JPMorgan said it will take on over $20 billion in card balances and book a $2.2 billion credit loss provision.
Seagate stock tumbles nearly 8% as AI-storage trade cools ahead of payrolls

Seagate stock tumbles nearly 8% as AI-storage trade cools ahead of payrolls

Seagate shares dropped 7.7% to $284.47 on Thursday, deepening a two-day slide among storage stocks as investors reduced tech exposure ahead of Friday’s U.S. jobs report. SanDisk fell 5.4% and Western Digital lost 6.1%. A U.S. appeals court revived Seagate’s antitrust claims against NHK Spring after the close. Seagate reports earnings January 20 and guided for Q2 revenue of $2.70 billion.
AST SpaceMobile stock snaps back after Scotiabank downgrade whipsaws Wall Street

AST SpaceMobile stock snaps back after Scotiabank downgrade whipsaws Wall Street

AST SpaceMobile shares rose 5.6% to $90.56 Thursday, rebounding after an analyst downgrade sent the stock tumbling the day before. Scotiabank cut its rating to underperform, citing slow service rollout and a lack of retail customers, while Bank of America raised its price target to $100. The stock remains volatile ahead of Friday’s U.S. jobs report and the company’s expected earnings in March.
9 January 2026
Home Depot (HD) stock jumps as Trump targets mortgage rates; payrolls, earnings loom

Home Depot (HD) stock jumps as Trump targets mortgage rates; payrolls, earnings loom

Home Depot shares jumped about 3% to $359.56 in after-hours trading Thursday, among the Dow’s top movers, after President Trump announced a $200 billion mortgage bond purchase to lower rates. Lowe’s and Sherwin-Williams also rose. Fannie Mae and Freddie Mac, named to handle the bond buy, had under $17 billion in cash as of September 30. Home Depot reports fourth-quarter earnings February 24.
9 January 2026
Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher shares fell 1.7% to $606.50 Thursday, extending losses after reaching a 52-week high of $628.08 earlier in the week. Trading volume topped 3 million shares, nearly double the average. The company will present at the J.P. Morgan Healthcare Conference on Jan. 13 and report earnings Jan. 29. Investors await updates on the $8.9 billion Clario acquisition, expected to close by mid-2026.
Coinbase (COIN) stock barely moves after BofA upgrade as CEO share sale filing hits

Coinbase (COIN) stock barely moves after BofA upgrade as CEO share sale filing hits

Coinbase shares slipped 0.1% to $245.59 in after-hours trading Thursday, despite a Bank of America upgrade to “buy” with a $340 price target. CEO Brian Armstrong sold 40,000 shares last week under a pre-set plan, leaving him with no direct Class A holdings. Barclays cut its price target to $258. Coinbase has launched zero-commission stock trading and prediction markets in the U.S.
9 January 2026
Mastercard stock steady as Apple taps JPMorgan for Apple Card — and keeps MA as the network

Mastercard stock steady as Apple taps JPMorgan for Apple Card — and keeps MA as the network

Apple said JPMorgan will take over as issuer of Apple Card in about two years, with Mastercard remaining the payment network. Mastercard shares held near $580 in after-hours trading Thursday. Visa closed down 1% at $352.23. Investors are watching Friday’s U.S. payrolls report and Mastercard’s upcoming earnings.
AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls

AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls

AbbVie shares fell 4% to $224.13 in after-hours trading Thursday after the company cut its 2025 adjusted profit forecast and disclosed a $1.3 billion acquired R&D charge. The company lowered its full-year 2025 adjusted EPS outlook to $9.90–$9.94 from $10.61–$10.65. AbbVie denied takeover talks with Revolution Medicines. Investors await the company’s Feb. 4 earnings report for further guidance.

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop